Motixafortide, sold under the brand name Aphexda, is a medication used for the treatment of multiple myeloma. Motixafortide is a hematopoietic stem cell...
9 KB (543 words) - 13:59, 5 September 2024
(Mozobil) was approved for medical use in the United States in 2008. Motixafortide (Aphexda) was approved for medical use in the United States in September...
131 KB (13,507 words) - 23:21, 24 October 2024